Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

A novel pharmacophore model for the design of anthrax lethal factor inhibitors.

Yuan H, Johnson SL, Chen LH, Wei J, Pellecchia M.

Chem Biol Drug Des. 2010 Sep 1;76(3):263-8. doi: 10.1111/j.1747-0285.2010.01000.x. Epub 2010 Jun 21.

PMID:
20572812
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Low molecular weight inhibitors of the protease anthrax lethal factor.

Dalkas GA, Papakyriakou A, Vlamis-Gardikas A, Spyroulias GA.

Mini Rev Med Chem. 2008 Mar;8(3):290-306. Review.

PMID:
18336349
[PubMed - indexed for MEDLINE]
3.

The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

Tonello F, Montecucco C.

Mol Aspects Med. 2009 Dec;30(6):431-8. doi: 10.1016/j.mam.2009.07.006. Epub 2009 Aug 7. Review.

PMID:
19665472
[PubMed - indexed for MEDLINE]
4.

Anthrax X-rayed: new opportunities for biodefence.

Stubbs MT.

Trends Pharmacol Sci. 2002 Dec;23(12):539-41. Review.

PMID:
12457764
[PubMed - indexed for MEDLINE]
5.

Quickening the pace of anthrax research: three advances point towards possible therapies.

Chaudry GJ, Moayeri M, Liu S, Leppla SH.

Trends Microbiol. 2002 Feb;10(2):58-62. Review.

PMID:
11827799
[PubMed - indexed for MEDLINE]
6.

Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.

Schein CH, Chen D, Ma L, Kanalas JJ, Gao J, Jimenez ME, Sower LE, Walter MA, Gilbertson SR, Peterson JW.

Toxins (Basel). 2012 Nov 8;4(11):1288-300. doi: 10.3390/toxins4111288. Review.

PMID:
23202316
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Polyvalency: a promising strategy for drug design.

Vance D, Shah M, Joshi A, Kane RS.

Biotechnol Bioeng. 2008 Oct 15;101(3):429-34. doi: 10.1002/bit.22056. Review.

PMID:
18727104
[PubMed - indexed for MEDLINE]
8.

Toxins of Bacillus anthracis.

Brossier F, Mock M.

Toxicon. 2001 Nov;39(11):1747-55. Review.

PMID:
11595637
[PubMed - indexed for MEDLINE]
9.

Discovery and development of anthrax lethal factor metalloproteinase inhibitors.

Turk BE.

Curr Pharm Biotechnol. 2008 Feb;9(1):24-33. Review.

PMID:
18289054
[PubMed - indexed for MEDLINE]
10.

[Anthrax toxins].

Brossier F, Guidi-Rontani C, Mock M.

C R Seances Soc Biol Fil. 1998;192(3):437-44. Review. French.

PMID:
9759382
[PubMed - indexed for MEDLINE]
11.

Anthrax toxin: a tripartite lethal combination.

Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C.

FEBS Lett. 2002 Nov 20;531(3):384-8. Review.

PMID:
12435580
[PubMed - indexed for MEDLINE]
Free Article
12.

Anthrax fusion protein therapy of cancer.

Frankel AE, Powell BL, Duesbery NS, Vande Woude GF, Leppla SH.

Curr Protein Pept Sci. 2002 Aug;3(4):399-407. Review.

PMID:
12370003
[PubMed - indexed for MEDLINE]
13.

Anthrax toxin: the long and winding road that leads to the kill.

Abrami L, Reig N, van der Goot FG.

Trends Microbiol. 2005 Feb;13(2):72-8. Review.

PMID:
15680766
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk